Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.72% |
| 2 | Healthcare | 2.38% |
| 3 | Financials | 2.3% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
ProShares UltraPro Russell2000
URTY
$354M
| $2.98M | ﹤0.01% |
39,628
-6,806
| -15% | -$518K |
|
5077
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.42B
| $2.98M | ﹤0.01% |
42,273
-10,612
| -20% | -$742K |
|
5078
PUT
LendingTree
TREE
$443M
| $2.98M | ﹤0.01% |
24,900
-4,200
| -14% | -$497K |
|
|
LOGC
5079
DELISTED
ContextLogic
LOGC
| $2.98M | ﹤0.01% |
44,134
-19,311
| -30% | -$1.36M |
|
|
SVNA
5080
DELISTED
7 Acquisition Corp
SVNA
| $2.98M | ﹤0.01% |
300,000
+60,000
| +25% | +$593K |
|
5081
CALL
iShares S&P GSCI Commodity-Indexed Trust
GSG
$941M
| $2.98M | ﹤0.01% |
131,500
+95,300
| +263% | +$1.96M |
|
5082
Mirion Technologies
MIR
$3.8B
| $2.98M | ﹤0.01% |
368,946
+262,497
| +247% | +$2.26M |
|
5083
PUT
Newmark Group
NMRK
$2.62B
| $2.98M | ﹤0.01% |
187,000
+48,300
| +35% | +$787K |
|
5084
MGP Ingredients
MGPI
$393M
| $2.98M | ﹤0.01% |
34,771
+18,259
| +111% | +$1.47M |
|
|
SGMO
5085
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.98M | ﹤0.01% |
512,208
-149,208
| -23% | -$887K |
|
|
SAGE
5086
PUT
DELISTED
Sage Therapeutics
SAGE
| $2.97M | ﹤0.01% |
89,800
-10,000
| -10% | -$376K |
|
|
CEQP
5087
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.97M | ﹤0.01% |
99,321
-4,213
| -4% | -$124K |
|
5088
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$523M
| $2.97M | ﹤0.01% |
+40,116
| New | +$2.95M |
|
5089
First Trust Emerging Markets AlphaDEX Fund
FEM
$781M
| $2.97M | ﹤0.01% |
118,114
-14,696
| -11% | -$379K |
|
5090
Nurix Therapeutics
NRIX
$2.69B
| $2.97M | ﹤0.01% |
211,783
+158,504
| +297% | +$2.81M |
|
5091
CALL
Astrana Health
ASTH
$1.71B
| $2.97M | ﹤0.01% |
61,200
-17,300
| -22% | -$892K |
|
5092
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.2M
| $2.96M | ﹤0.01% |
46,837
+42,029
| +874% | +$2.69M |
|
|
AMK
5093
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $2.96M | ﹤0.01% |
133,208
-86,431
| -39% | -$2.04M |
|
5094
PUT
Paylocity
PCTY
$7.7B
| $2.96M | ﹤0.01% |
14,400
-4,200
| -23% | -$850K |
|
|
ISBC
5095
DELISTED
Investors Bancorp, Inc.
ISBC
| $2.96M | ﹤0.01% |
198,247
+124,839
| +170% | +$2.04M |
|
|
CEQP
5096
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.96M | ﹤0.01% |
98,850
-49,150
| -33% | -$1.44M |
|
5097
Sabesp
SBS
$17.7B
| $2.96M | ﹤0.01% |
1,551,350
-733,417
| -32% | -$1.08M |
|
5098
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.37B
| $2.96M | ﹤0.01% |
35,284
+4,076
| +13% | +$335K |
|
|
GPP
5099
CALL
DELISTED
Green Plains Partners LP
GPP
| $2.96M | ﹤0.01% |
208,700
+88,700
| +74% | +$1.26M |
|
5100
TIM SA
TIMB
$8.62B
| $2.95M | ﹤0.01% |
203,759
+171,435
| +530% | +$2.16M |
|
Similar funds
Citadel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
- Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.